Remaining assays from the 2022-2023 season, highlights include: 446 m of 0.63% Cu, including 76 m of 0.92% Cu (AZ23228MET) TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) [...]
SEATTLE, Feb. 26, 2024 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that […]